Moderately Hypofractionated Proton Beam Therapy for Locally Advanced Non-Small Cell Lung Cancer: A New Way Forward for Dose Escalation?

Affiliations

¹ Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, Ohio.
² Department of Radiation Oncology, Duke University School of Medicine, Durham, North Carolina; Radiation Oncology Service, Durham Veterans Affairs Health Care System, Durham, North Carolina. Electronic address: joseph.salama@duke.edu.

Editorial

Jeremy Brownstein et al. Int J Radiat Oncol Biol Phys. 2022.

. 2022 Jul 15;113(4):749-751.

doi: 10.1016/j.ijrobp.2022.04.023.

¹ Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, Ohio.
² Department of Radiation Oncology, Duke University School of Medicine, Durham, North Carolina; Radiation Oncology Service, Durham Veterans Affairs Health Care System, Durham, North Carolina. Electronic address: joseph.salama@duke.edu.

No abstract available

Comment on

Phase I Study of Accelerated Hypofractionated Proton Therapy and Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer.
Contreras J, Srivastava A, Samson P, DeWees T, Govindan R, Baggstrom MQ, Morgensztern D, Roach M, Badiyan SN, Bradley J, Waqar S, Robinson C. Contreras J, et al. Int J Radiat Oncol Biol Phys. 2022 Jul 15;113(4):742-748. doi: 10.1016/j.ijrobp.2022.01.012. Epub 2022 Jan 22. Int J Radiat Oncol Biol Phys. 2022. PMID: 35074432 Clinical Trial.
Chemoradiation with Hypofractionated Proton Therapy in Stage II-III Non-Small Cell Lung Cancer: A Proton Collaborative Group Phase 2 Trial.
Hoppe BS, Nichols RC, Flampouri S, Pankuch M, Morris CG, Pham DC, Mohindra P, Hartsell WF, Mohammed N, Chon BH, Kestin LL, Simone CB 2nd. Hoppe BS, et al. Int J Radiat Oncol Biol Phys. 2022 Jul 15;113(4):732-741. doi: 10.1016/j.ijrobp.2022.03.005. Epub 2022 Mar 17. Int J Radiat Oncol Biol Phys. 2022. PMID: 35306151 Clinical Trial.